British watchdog rejects GSK's lupus drug again

LONDON (Reuters) - Britain's healthcare cost watchdog has rejected GlaxoSmithKline's lupus drug Benlysta a second time after the company offered an undisclosed discount, saying it still failed to offer good value for money.

Source: Reuters: Health - July 24, 2013 Category: Consumer Health News Tags: healthNews Source Type: news